Evaluation of the Effects of a Technologically-Enhanced Personal Coaching Program on Hemoglobin A1c in Type 2 Diabetics
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 72
- 试验地点
- 2
- 主要终点
- Change in Hemoglobin A1c
研究概览
简要总结
Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced using an mobile application and care management platform.
详细描述
Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced by integrating a participant-facing mobile application with the coaching platform. Blood glucose test results automatically populate the coaching platform, providing the CDE with information that may better support their coaching efforts.
The participants complete Diabetes Self Management Education (DSME) learning modules for the first 7-12 weeks. Following completion of the modules, the coach continues to provide support to the participant until 24 weeks after the participant's enrollment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Lives in the United States
- •Speaks and understands English
- •Has a Type 2 diabetes mellitus diagnosis
- •Has a LifeScan Verio Flex blood glucose meter, which is connected to OneTouch Reveal ® app
- •Has a verified A1c ≥ 8%
- •Willing to participate in coaching program
排除标准
- •Uses a continuous glucose monitoring device
- •Currently pregnant
- •Unable to make lifestyle behavioral changes due to a cognitive or physical disability
- •Has end stage renal disease (ESRD) diagnosis
- •Is not able to read or understand English
研究组 & 干预措施
Live diabetes coaching program
Live diabetes coaching program
干预措施: Live diabetes coaching program (Behavioral)
结局指标
主要结局
Change in Hemoglobin A1c
时间窗: A1c measured at baseline, at 12 weeks since study enrollment, and at 24 weeks since enrollment, which marks the participant's completion of the study
Blood serum test to measure glucose control
次要结局
未报告次要终点
研究者
Kristin Neland
Clinical Program Designer
Welkin Health